Patents by Inventor Paul L. Termin

Paul L. Termin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7909886
    Abstract: This invention is directed to prosthesis, which, when implanted into a mammalian patient, serves as a functioning replacement for a body part, or tissue structure, and will undergo controlled biodegradation occurring concomitantly with bioremodeling by the patient's living cells. The prosthesis is treated so that it is rendered non-antigenic so as not to elicit a significant humoral immune response. The prosthesis of this invention, in its various embodiments, thus has dual properties. First, it functions as a substitute body part, and second, it functions as bioremodeling template for the ingrowth of host cells.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: March 22, 2011
    Assignee: Organogenesis, Inc.
    Inventors: Robert M. Carr, Jr., Kimberlie D. Condon, Paul L. Termin, Janet Hardin Young
  • Patent number: 7060103
    Abstract: A prosthesis, which, when implanted into a mammalian patient, serves as a functioning replacement for a body part, or tissue structure, and will undergo controlled biodegradation occurring concomitantly with bioremodeling by the patients living cells. The prosthesis is treated so that it is rendered non-antigenic so as not to elicit a significant humoral immune response. The prosthesis, in its various embodiments, thus has dual properties. First, it functions as a substitute body part, and second, it functions as bioremodeling template for the ingrowth of host cells.
    Type: Grant
    Filed: February 28, 2003
    Date of Patent: June 13, 2006
    Assignee: Organogenesis Inc.
    Inventors: Robert M. Carr, Jr., Kimberlie D. Condon, Paul L. Termin, Janet Hardin Young
  • Patent number: 6890351
    Abstract: A bioremodelable prosthesis for treating a patient with a diseased or damaged organs comprising a first layer that contains acid-extracted fibrillar or non-fibrillar collagen, and a second layer derived from the tunica submucosa of the small intestine that provides structural stability, is pliable and is semi-permeable,pe1 59564443.npc wherein the prosthesis undergoes controlled biodegradation occurring with adequate living cell replacement such that the original prosthesis is replaced by the patient's living cells.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: May 10, 2005
    Assignee: Organogenesis Inc.
    Inventors: Paul L. Termin, Robert M. Carr, Jr., Kimberlie D. Condon
  • Publication number: 20030158607
    Abstract: This invention is directed to prosthesis, which, when implanted into a mammalian patient, serves as a functioning replacement for a body part, or tissue structure, and will undergo controlled biodegradation occurring concomitantly with bioremodeling by the patient's living cells. The prosthesis is treated so that it is rendered non-antigenic so as not to elicit a significant humoral immune response. The prosthesis of this invention, in its various embodiments, thus has dual properties. First, it functions as a substitute body part, and second, it functions as bioremodeling template for the ingrowth of host cells.
    Type: Application
    Filed: February 28, 2003
    Publication date: August 21, 2003
    Inventors: Robert M. Carr, Kimberlie D. Condon, Paul L. Termin, Janet Hardin Young
  • Publication number: 20020095218
    Abstract: This invention is directed to prosthesis, which, when implanted into a mammalian patient, serves as a functioning replacement for a body part, or tissue structure, and will undergo controlled biodegradation occurring concomitantly with bioremodeling by the patient's living cells. The prosthesis is treated so that it is rendered non-antigenic so as not to elicit a significant humoral immune response. The prosthesis of this invention, in its various embodiments, thus has dual properties. First, it functions as a substitute body part, and second, it functions as bioremodeling template for the ingrowth of host cells.
    Type: Application
    Filed: April 26, 2001
    Publication date: July 18, 2002
    Inventors: Robert M. Carr, Kimberlie D. Condon, Paul L. Termin, Janet Hardin Young
  • Publication number: 20020019663
    Abstract: This invention is directed to a method of treating a patient with diseased or damaged organs comprising administering to said patient a bioremodelable collagen-containing material which promotes the production of structural collagen, vascularization and epithelialization by the ingrowth of patient cells, wherein the material undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted graft is bioremodeled by the patient's living cells.
    Type: Application
    Filed: September 7, 2001
    Publication date: February 14, 2002
    Inventors: Paul L. Termin, Robert M. Carr, Kimberlie D. Condon
  • Patent number: 6334872
    Abstract: This invention is directed to a method of treating a patient with diseased or damaged organs comprising administering to said patient a bioremodelable collagen-containing material which promotes the production of structural collagen, vascularization and epithelialization by the ingrowth of patient cells, wherein the material undergoes controlled biodegradation occurring with adequate living cell replacement such that the original implanted graft is bioremodeled by the patient's living cells.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: January 1, 2002
    Assignee: Organogenesis Inc.
    Inventors: Paul L. Termin, Robert M. Carr, Jr., Kimberlie D. Condon
  • Patent number: 5733337
    Abstract: This invention is directed to prosthesis, which, when implanted into a mammalian patient, serve as a functioning replacement for a body part, or tissue structure, and will undergo controlled biodegradation occurring concomitantly with bioremodeling by the patient's living cells. The prosthesis of this invention, in its various embodiments, thus has dual properties. First, it functions as a substitute body part, and second, it functions as bioremodeling template for the ingrowth of host cells.
    Type: Grant
    Filed: April 7, 1995
    Date of Patent: March 31, 1998
    Assignee: Organogenesis, Inc.
    Inventors: Robert M. Carr, Jr., Paul L. Termin, Kimberlie D. Condon
  • Patent number: 5496277
    Abstract: An open weave fixation device is secured to a distal end region of a catheter or other diagnostic or treatment device, for either temporarily or permanently fixing the device within a body cavity. In one approach, the fixation element is constructed of braided, helically wound filaments of resilient stainless steel. A sheath surrounds the catheter and fixation element to elastically deform the element into a reduced radius configuration to facilitate insertion and deployment. With the fixation element positioned as desired, the sheath is withdrawn to permit the fixation element to self-expand against body tissue, thus to secure the fixation element and catheter. In all alternative arrangement, a dilatation balloon surrounds a catheter near its distal end, and in turn is surrounded by a plastically deformable fixation element. Following desired positioning, the balloon is dilated to permanently deform the fixation element into contact with body tissue.
    Type: Grant
    Filed: November 22, 1994
    Date of Patent: March 5, 1996
    Assignee: Schneider (USA) Inc.
    Inventors: Paul L. Termin, Christopher H. Porter
  • Patent number: 5378239
    Abstract: An open weave fixation device is secured to a distal end region of a catheter or other diagnostic or treatment device, for either temporarily or permanently fixing the device within a body cavity. In one approach, the fixation element is constructed of braided, helically wound filaments of resilient stainless steel. A sheath surrounds the catheter and fixation element to elastically deform the element into a reduced radius configuration to facilitate insertion and deployment. With the fixation element positioned as desired, the sheath is withdrawn to permit the fixation element to self-expand against body tissue, thus to secure the fixation element and catheter. In an alternative arrangement, a dilatation balloon surrounds a catheter near its distal end, and in turn is surrounded by a plastically deformable fixation element. Following desired positioning, the balloon is dilated to permanently deform the fixation element into contact with body tissue.
    Type: Grant
    Filed: June 22, 1993
    Date of Patent: January 3, 1995
    Assignee: Schneider (USA) Inc.
    Inventors: Paul L. Termin, Christopher H. Porter
  • Patent number: 5221261
    Abstract: An open weave fixation device is secured to a distal end region of a catheter or other diagnostic or treatment device, for either temporarily or permanently fixing the device within a body cavity. In one approach, the fixation element is constructed of braided, helically wound filaments of resilient stainless steel. A sheath surrounds the catheter and fixation element to elastically deform the element into a reduced radius configuration to facilitate insertion and deployment. With the fixation element positioned as desired, the sheath is withdrawn to permit the fixation element to self-expand against body tissue, thus to secure the fixation element and catheter. In an alternative arrangement, a dilation balloon surrounds a catheter near its distal end, and in turn is surrounded by a plastically deformable fixation element. Following desired positioning, the balloon is dilated to permanently deform the fixation element into contact with body tissue.
    Type: Grant
    Filed: August 10, 1992
    Date of Patent: June 22, 1993
    Assignee: Schneider (USA) Inc.
    Inventors: Paul L. Termin, Christopher H. Porter
  • Patent number: 5071407
    Abstract: An open weave fixation device is secured to a distal end region of a catheter or other diagnostic or treatment device, for either temporarily or permanently fixing the device within a body cavity. In one approach, the fixation element is constructed of braided, helically wound filaments of resilient stainless steel. A sheath surrounds the catheter and fixation element to elastically deform the element into a reduced radius configuration to facilitate insertion and deployment. With the fixation element positioned as desired, the sheath is withdrawn to permit the fixation element to self-expand against body tissue, thus to secure the fixation element and catheter. In an alternative arrangement, a dilatation balloon surrounds a catheter near its distal end, and in turn is surrounded by a plastically deformable fixation element. Following desired positioning, the balloon is dilated to permanently deform the fixation element into contact with body tissue.
    Type: Grant
    Filed: April 12, 1990
    Date of Patent: December 10, 1991
    Assignee: Schneider (U.S.A.) Inc.
    Inventors: Paul L. Termin, Christopher H. Porter